B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 5, Issue 2, Pages e282-e282
Publisher
Springer Nature
Online
2015-02-27
DOI
10.1038/bcj.2015.3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A critical role for the NFkB pathway in multiple myeloma
- (2015) Oncotarget
- Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
- (2014) Y.-T. Tai et al. BLOOD
- Microenvironment and multiple myeloma spread
- (2014) Domenico Ribatti et al. THROMBOSIS RESEARCH
- BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma
- (2013) L. Bolkun et al. ANNALS OF HEMATOLOGY
- B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
- (2013) R. O. Carpenter et al. CLINICAL CANCER RESEARCH
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Evaluation of TNF superfamily molecules in multiple myeloma patients: Correlation with biological and clinical features
- (2013) Dorota Lemancewicz et al. LEUKEMIA RESEARCH
- Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma
- (2013) Michael G. Alexandrakis et al. Biomed Research International
- B cell-activating factor: its clinical significance in multiple myeloma patients
- (2012) M. Fragioudaki et al. ANNALS OF HEMATOLOGY
- Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival
- (2012) Eric Sanchez et al. BRITISH JOURNAL OF HAEMATOLOGY
- BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells
- (2012) G. Xu et al. CYTOKINE
- Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma
- (2012) M. Fragioudaki et al. LEUKEMIA RESEARCH
- Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas
- (2011) M. Guadagnoli et al. BLOOD
- BAFF-R gene induced by IFN-γ in multiple myeloma cells is related to NF-κB signals
- (2011) Xianjuan Shen et al. CELL BIOCHEMISTRY AND FUNCTION
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- APRIL is overexpressed in cancer: link with tumor progression
- (2009) Jérôme Moreaux et al. BMC CANCER
- Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study
- (2009) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop
- (2009) Jérôme Moreaux et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas
- (2009) Kiriko Wada et al. HISTOPATHOLOGY
- Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor
- (2009) L. Zhang et al. JOURNAL OF NEUROSCIENCE
- New targets of PS-341: BAFF and APRIL
- (2009) Wuping Li et al. MEDICAL ONCOLOGY
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Correlation of expression levels of BLyS and its receptors with multiple myeloma
- (2008) Shaoqing Ju et al. CLINICAL BIOCHEMISTRY
- B-Lymphocyte stimulator: a new biomarker for multiple myeloma
- (2008) Pu Jiang et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
- (2008) I Breitkreutz et al. LEUKEMIA
- NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells
- (2008) Y. Sasaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils
- (2007) Patrizia Scapini et al. IMMUNOLOGY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search